Delayed
Hong Kong S.E.
11:28:59 2024-05-01 pm EDT
|
5-day change
|
1st Jan Change
|
0.068
HKD
|
+4.62%
|
|
+6.25%
|
+1.49%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,400
|
911.8
|
881.4
|
553.2
|
412
|
405.9
|
Enterprise Value (EV)
1 |
587.7
|
493.2
|
377.9
|
44.66
|
-48.76
|
-44.65
|
P/E ratio
|
32.2
x
|
-2.16
x
|
-4.76
x
|
-14
x
|
-4.22
x
|
-6.56
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
7.83
x
|
4.54
x
|
5.88
x
|
2.71
x
|
2.47
x
|
2.89
x
|
EV / Revenue
|
3.29
x
|
2.46
x
|
2.52
x
|
0.22
x
|
-0.29
x
|
-0.32
x
|
EV / EBITDA
|
-3.54
x
|
-4.99
x
|
-4.28
x
|
-0.68
x
|
0.76
x
|
0.73
x
|
EV / FCF
|
0.87
x
|
-1.22
x
|
1.1
x
|
6.77
x
|
2.1
x
|
0.38
x
|
FCF Yield
|
115%
|
-81.8%
|
91.1%
|
14.8%
|
47.6%
|
262%
|
Price to Book
|
0.49
x
|
0.39
x
|
0.39
x
|
0.24
x
|
0.2
x
|
0.22
x
|
Nbr of stocks (in thousands)
|
6,061,399
|
6,078,944
|
6,078,944
|
6,078,944
|
6,058,772
|
6,058,772
|
Reference price
2 |
0.2310
|
0.1500
|
0.1450
|
0.0910
|
0.0680
|
0.0670
|
Announcement Date
|
4/17/19
|
4/27/20
|
4/15/21
|
4/20/22
|
4/20/23
|
4/22/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
178.9
|
200.8
|
149.9
|
203.8
|
166.5
|
140.3
|
EBITDA
1 |
-166
|
-98.87
|
-88.32
|
-65.77
|
-64.03
|
-61.34
|
EBIT
1 |
-177.9
|
-109.8
|
-99
|
-76.12
|
-69.18
|
-65.9
|
Operating Margin
|
-99.44%
|
-54.7%
|
-66.05%
|
-37.35%
|
-41.56%
|
-46.96%
|
Earnings before Tax (EBT)
1 |
91.16
|
-480.1
|
-200.7
|
-46.62
|
-102.7
|
-68.78
|
Net income
1 |
43.45
|
-422.4
|
-185.3
|
-39.41
|
-97.7
|
-61.88
|
Net margin
|
24.29%
|
-210.4%
|
-123.64%
|
-19.34%
|
-58.68%
|
-44.09%
|
EPS
2 |
0.007173
|
-0.0696
|
-0.0305
|
-0.006483
|
-0.0161
|
-0.0102
|
Free Cash Flow
1 |
676.6
|
-403.4
|
344.2
|
6.601
|
-23.19
|
-116.8
|
FCF margin
|
378.21%
|
-200.95%
|
229.63%
|
3.24%
|
-13.93%
|
-83.21%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
1,557.11%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/17/19
|
4/27/20
|
4/15/21
|
4/20/22
|
4/20/23
|
4/22/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
813
|
419
|
504
|
509
|
461
|
451
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
677
|
-403
|
344
|
6.6
|
-23.2
|
-117
|
ROE (net income / shareholders' equity)
|
0.98%
|
-16.7%
|
-7.9%
|
-1.61%
|
-4.26%
|
-3.01%
|
ROA (Net income/ Total Assets)
|
-2.91%
|
-2.01%
|
-2.11%
|
-1.69%
|
-1.65%
|
-1.79%
|
Assets
1 |
-1,494
|
20,977
|
8,795
|
2,339
|
5,935
|
3,451
|
Book Value Per Share
2 |
0.4700
|
0.3900
|
0.3800
|
0.3800
|
0.3400
|
0.3100
|
Cash Flow per Share
2 |
0.1300
|
0.0700
|
0.0800
|
0.0400
|
0.0300
|
0.0300
|
Capex
1 |
38
|
31.1
|
9.71
|
1.58
|
1.15
|
1.37
|
Capex / Sales
|
21.27%
|
15.49%
|
6.48%
|
0.77%
|
0.69%
|
0.98%
|
Announcement Date
|
4/17/19
|
4/27/20
|
4/15/21
|
4/20/22
|
4/20/23
|
4/22/24
|
|
1st Jan change
|
Capi.
|
---|
| +1.49% | 50.34M | | -28.69% | 70.69B | | +14.32% | 81.84B | | +9.37% | 29.03B | | -11.43% | 16.97B | | -0.36% | 16.83B | | -0.24% | 15.28B | | +4.32% | 12.41B | | +33.40% | 12.26B | | -31.58% | 11.83B |
Other Healthcare Facilities & Services
|